Back

Ranolazine - a new therapeutic option for patients with ventricular cardiac arrhythmias?

26 August 2017 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Ventricular arrhythmias Ventricular arrhythmias ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Blazej Kusz

Upper Silesian Cardiology Centre, Katowice (Poland)

19 More presentations in this session

Presentation thumbnail
Mr D. Penela (Barcelona, ES)
Presentation thumbnail
Doctor C. Ellermann (Muenster, DE)
Abstract
Presentation thumbnail
Professor J. Gourraud (Nantes, FR)
Abstract Slides
Presentation thumbnail
Doctor J. Fernandez-Armenta Pastor (Cadiz, ES)
Abstract
Presentation thumbnail
Professor M. Takagi (Moriguchi, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Ventricular arrhythmias

The Event

Event poster

ESC Congress 2017

26 August 2017 11:00 CET
You may be interested in
thumbnail
Congress Presentation
The role of Ranolazine alone or in combination with a Class III anti-arrhythmic drug for DC cardioversion for persistent AF
7 April 2024
thumbnail
Webinar
The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines
2 April 2024
thumbnail
Congress Presentation
Questions & answers
31 August 2024
thumbnail
Congress Session
Ventricular storm (3)
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources